advanced search
Dr Daniel Palmer

Is this your profile?

About

Daniel Palmer, PhD, was the Chief Scientific Officer for Midatech Pharma until 2016.

Contributions

OCULAR
OPSISPORIN: A LONG-ACTING DRUG DELIVERY APPROACH FOR UVEITIS
Here, Paul Seaman and Daniel Palmer discuss Midatech Pharma’s next generation treatments for auto-immune ocular diseases, which use a combination of innovative, sustained-release drug products.
Top